6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
7m ago	Yapi ve Kredi Bankasi : Successful issuance of 500 million US$ perpetual Additional Tier 1 Capital Transaction
12m ago	Crown Castle Names Kris Hinson as Chief Commercial Officer and Mark Lennon as Chief Information Officer
17m ago	Hovnanian Enterprises Reports Fiscal 2026 Second Quarter Results
17m ago	LivaNova Appoints Stefano Folli to Lead its Cardiopulmonary Business Unit
17m ago	KKR Sells CIRCOR Aerospace to Parker Hannifin for $2.55 Billion

About

7.93USD+0.11 +1.41%

Closed • Updated at 13:33 GMT+00:00

Market Cap$622.12M

P/E Ratio3.78

Volume1.42M

Beta0.28

RSI56.80

Gross Margin85.83%

Health TechnologyBiotechnology

Cormedix Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Cormedix Therapeutics to Participate in two Upcoming Investor Conferences

Cormedix Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

CorMedix Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 14, 2026

CorMedix Therapeutics Announces Positive Topline Results from Phase III ReSPECT Trial Assessing REZZAYO® for the Prophylaxis of Invasive Fungal Diseases in Allogeneic Hematopoietic Stem Cell Transplantation Patients

CorMedix to Participate in Needham Virtual Healthcare Conference

Community Chat

Ask AI